INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Scope & Guideline

Pioneering insights in gynecological cancer treatment.

Introduction

Explore the comprehensive scope of INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1048-891x
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1991 to 2024
AbbreviationINT J GYNECOL CANCER / Int. J. Gynecol. Cancer
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER focuses on advancing the field of gynecological oncology through the dissemination of high-quality research. Its primary aim is to publish studies that enhance understanding, diagnosis, and treatment of gynecological cancers, thereby improving patient outcomes.
  1. Clinical Trials and Treatment Strategies:
    The journal emphasizes the importance of clinical trials, showcasing innovative treatment strategies and their effectiveness in managing gynecological cancers, including surgical techniques, chemotherapy regimens, and emerging therapies.
  2. Molecular and Genetic Research:
    A significant focus is placed on the molecular and genetic underpinnings of gynecological cancers, exploring biomarkers and genetic mutations that inform treatment decisions and prognostic assessments.
  3. Patient-Centered Outcomes:
    Research on patient-reported outcomes and quality of life is crucial, as the journal aims to understand the impact of gynecological cancer treatments on patients’ overall wellbeing and satisfaction.
  4. Surgical Techniques and Innovations:
    The journal covers advancements in surgical techniques, including minimally invasive approaches, robotic surgeries, and novel methods for lymph node mapping, which are essential for improving surgical outcomes.
  5. Epidemiological Studies and Health Disparities:
    The journal addresses epidemiological studies that highlight disparities in gynecological cancer incidence and treatment outcomes across different demographics, emphasizing the need for equitable healthcare access.
The journal has shown a dynamic evolution in its research themes, with several areas gaining prominence. These emerging scopes reflect current advancements in technology, treatment modalities, and patient care practices.
  1. Immunotherapy and Targeted Therapies:
    There is a growing focus on immunotherapy and targeted therapies, such as PARP inhibitors and monoclonal antibodies, reflecting the shift towards personalized medicine in treating gynecological cancers.
  2. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning in diagnostics and treatment planning is increasingly prominent, showcasing innovative approaches to improve patient outcomes and streamline research.
  3. Integrative and Multidisciplinary Approaches:
    Research emphasizing integrative approaches that combine surgical, medical, and supportive care strategies is trending, highlighting the importance of comprehensive patient management.
  4. Quality of Life and Patient Satisfaction Studies:
    There is an emerging trend towards understanding the quality of life and satisfaction among patients undergoing treatment for gynecological cancers, emphasizing the importance of patient-centered care.
  5. Health Disparities and Global Perspectives:
    Research addressing health disparities and the global burden of gynecological cancers is increasingly relevant, as it calls for strategies to improve access and outcomes across diverse populations.

Declining or Waning

While the journal has seen a rise in certain areas of research, some themes appear to be declining in focus. This may reflect shifts in research priorities or advancements in treatment that make previous topics less relevant.
  1. Traditional Chemotherapy Studies:
    Studies focusing solely on traditional chemotherapy regimens without incorporating novel agents or personalized medicine approaches are becoming less frequent, as the field moves toward more targeted therapies.
  2. Basic Surgical Techniques:
    Research centered on basic surgical techniques is waning, with a notable shift towards more complex procedures and robotic-assisted surgeries that emphasize precision and innovation.
  3. Non-Molecular Biomarker Studies:
    The emphasis on non-molecular biomarkers is decreasing as the field increasingly prioritizes genetic and molecular profiling to inform treatment decisions.
  4. Outdated Screening Methods:
    Research on older screening methods for gynecological cancers is diminishing, reflecting the shift towards more advanced, efficient, and patient-friendly screening options, such as HPV self-testing.

Similar Journals

Journal of Minimally Invasive Gynecology

Exploring the Future of Women's Health with Innovative Surgical Approaches.
Publisher: ELSEVIER SCIENCE INCISSN: 1553-4650Frequency: 6 issues/year

The Journal of Minimally Invasive Gynecology, published by Elsevier Science Inc, stands as a premier platform dedicated to advancing the field of obstetrics and gynecology with a specific focus on minimally invasive techniques. With an impressive impact factor that reflects its significance within the field, this journal is ranked in the Q1 category for Obstetrics and Gynecology, placing it among the top 25% of journals in its domain. Since its inception in 2005, it has consistently provided high-quality research, clinical insights, and innovative findings that are crucial for professionals, researchers, and students eager to stay abreast of the latest advancements. The journal operates on a hybrid open access model, ensuring that valuable knowledge is widely disseminated while promoting academic exchange across its converged years leading up to 2024. As it continues to publish cutting-edge studies, the Journal of Minimally Invasive Gynecology remains a vital resource for those committed to improving patient outcomes and enhancing surgical practices through minimally invasive methodologies.

Journal of the Turkish-German Gynecological Association

Pioneering Research for Enhanced Patient Outcomes
Publisher: GALENOS PUBL HOUSEISSN: 1309-0399Frequency: 4 issues/year

The Journal of the Turkish-German Gynecological Association, published by GALENOS PUBL HOUSE, stands as a significant contribution to the field of obstetrics and gynecology, fostering a vital dialogue between Turkish and German medical communities since its establishment. This peer-reviewed, Open Access journal, which has been accessible since 2000, provides a platform for the dissemination of cutting-edge research, clinical practices, and reviews that are pivotal for advancing women's health. With a current impact factor correlation reflecting its status within the Q3 category in the obstetrics and gynecology domain, the journal is ranked #108 out of 209 in Scopus, placing it in the 48th percentile for its field. Covering a broad range of topics from innovative treatment methods to emerging technologies in gynecology, this journal is dedicated to enriching the academic landscape and providing healthcare professionals, researchers, and students with valuable insights and knowledge essential for improving patient outcomes. The journal’s headquarters in Turkey underscores its commitment to enriching local and international discourse in women's health.

SURGICAL ONCOLOGY-OXFORD

Elevating surgical techniques through cutting-edge scholarship.
Publisher: ELSEVIER SCI LTDISSN: 0960-7404Frequency: 4 issues/year

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

BREAST CANCER RESEARCH AND TREATMENT

Innovating Research, Transforming Treatment
Publisher: SPRINGERISSN: 0167-6806Frequency: 18 issues/year

Breast Cancer Research and Treatment, published by Springer, stands as a pivotal journal within the domains of Cancer Research and Oncology, exemplified by its impressive Q2 and Q1 quartile rankings, respectively, in the 2023 category rankings. Since its inception in 1981, this journal has provided a vital platform for disseminating cutting-edge research focused on all aspects of breast cancer, ranging from molecular biology to treatment strategies. With an ISSN of 0167-6806 and E-ISSN of 1573-7217, it captures a broad audience of researchers, clinicians, and students dedicated to improving patient outcomes. The journal emphasizes high-quality, peer-reviewed studies that pave the way for advancements in therapy and direct novel insights into oncological practices. By maintaining a strong ranking in Scopus with percentile placements of 74th in Oncology and 61st in Cancer Research, Brest Cancer Research and Treatment continues to foster innovation and collaboration in the fight against breast cancer.

Taiwanese Journal of Obstetrics & Gynecology

Fostering Excellence in Obstetrics and Gynecology Scholarship
Publisher: ELSEVIER TAIWANISSN: 1028-4559Frequency: 4 issues/year

Taiwanese Journal of Obstetrics & Gynecology, published by Elsevier Taiwan, stands as a leading platform in the field of obstetrics and gynecology, fostering academic discourse and innovative research since its inception in 2004. With an impact factor that places it in the Q2 category of its field, it ranks #84 out of 209 journals in Obstetrics and Gynecology according to Scopus, indicating a significant reputation within the medical community. This open access journal ensures wide dissemination of research findings, allowing professionals, researchers, and students alike to stay updated with the latest advancements and practices. The journal's focus on publishing high-quality, peer-reviewed articles covers a broad range of topics within the field, making it an essential resource for those interested in women's health issues, clinical practices, and medical advancements in Taiwan and beyond. With its commitment to excellence, the Taiwanese Journal of Obstetrics & Gynecology invites contributions that enhance the understanding and management of obstetric and gynecological care.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Exploring breakthroughs in gastrointestinal research.
Publisher: SPRINGERISSN: 0179-1958Frequency: 1 issue/year

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

Clinical Medicine Insights-Oncology

Empowering oncologists with cutting-edge insights.
Publisher: SAGE PUBLICATIONS LTDISSN: Frequency: 1 issue/year

Clinical Medicine Insights-Oncology is a leading journal published by SAGE Publications Ltd, focusing on the interdisciplinary aspects of oncology. With an open access model since 2007, this journal fosters the dissemination of high-quality research and clinical insights that are crucial for advancing knowledge in cancer treatment and management. Based in New Zealand, it aims to bridge gaps in current oncology practices through the publication of innovative studies, case reports, and reviews. With a respectable ranking in Scopus at #264 out of 404 journals in the oncology category and belonging to the Q3 quartile, it positions itself as a valuable resource for oncologists, researchers, and students committed to enhancing patient outcomes. This journal strives to provide a platform for groundbreaking research that can impact clinical practice and inform policy within the field of oncology.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY

Shaping the Future of Gynecological Oncology
Publisher: MRE PRESSISSN: 0392-2936Frequency: 6 issues/year

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY is a pivotal publication in the field of gynecological oncology, dedicated to advancing research and clinical practices. Established in 1980 and published by MRE PRESS, this journal serves as a platform for disseminating high-quality research, reviews, and case studies pertaining to the diagnosis and treatment of gynecological cancers. Although the journal currently operates without an open access option, it remains a valuable resource for professionals seeking to stay abreast of the latest developments and findings within the field. The journal is indexed in both Scopus and other reputable databases, contributing significantly to the ongoing discourse in medicine with a particular focus on obstetrics, gynecology, and oncology, although it has seen a discontinuation in coverage by Scopus post-2021. With an emphasis on rigorous peer-review and scholarly integrity, the EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY continues to play an essential role in fostering knowledge and innovation among researchers, clinicians, and students committed to improving patient outcomes in gynecological health.

Frontiers in Oncology

Unlocking the future of cancer care through shared knowledge.
Publisher: FRONTIERS MEDIA SAISSN: 2234-943XFrequency: 1 issue/year

Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.

LUNG CANCER

Innovating Solutions for Lung Cancer Challenges
Publisher: ELSEVIER IRELAND LTDISSN: 0169-5002Frequency: 12 issues/year

LUNG CANCER, published by Elsevier Ireland Ltd, is a pivotal academic journal dedicated to advancing knowledge in the fields of Cancer Research, Oncology, and Pulmonary and Respiratory Medicine. With an impressive impact factor reflected by its Q1 ranking across three key categories for 2023, this journal occupies a prestigious position within the research community, emphasizing quality and significance in published works. Since its inception in 1985, LUNG CANCER has provided a comprehensive platform for researchers and clinicians to disseminate findings and novel insights, enhancing the understanding and treatment of lung cancer. The journal stands out with Scopus rankings, placing it in the top percentile across multiple relevant fields, including a notable rank of #20 in Pulmonary and Respiratory Medicine. By fostering collaboration among scholars, the journal aims to facilitate innovative research and promote evidence-based practices that could transform patient outcomes. As such, LUNG CANCER is an essential resource for those navigating this complex area of study, from seasoned researchers to aspiring professionals.